SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Wolff M.) "

Sökning: WFRF:(Wolff M.)

  • Resultat 51-60 av 213
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  • Wertheimer, T, et al. (författare)
  • Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis
  • 2021
  • Ingår i: Annals of hematology. - : Springer Science and Business Media LLC. - 1432-0584 .- 0939-5555. ; 100:3, s. 779-787
  • Tidskriftsartikel (refereegranskat)abstract
    • The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of abatacept for cGvHD therapy in a retrospective study with 15 patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) and received abatacept for cGvHD with a median age of 49 years. Grading was performed as part of the clinical routine according to the National Institute of Health’s (NIH) consensus criteria at initiation of abatacept and 1, 3, 6, 9 and 12 months thereafter. The median time of follow-up was 191 days (range 55–393 days). Best overall response rate (ORR) was 40%. In particular, patients with bronchiolitis obliterans syndrome showed significant clinical improvement and durable responses following abatacept treatment with a response rate of 89% based on improvement in lung severity score (n = 6) or stabilized lung function (n = 4) or both (n = 3). Infectious complications CTCAE °III or higher were observed in 3/15 patients. None of the patients relapsed from the underlying malignancy. Thus, abatacept appears to be a promising treatment option for cGvHD, in particular for patients with lung involvement. However, further evaluation within a phase 2 clinical trial is required.
  •  
52.
  • Abdel-Aziz, MI, et al. (författare)
  • A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric Asthma
  • 2021
  • Ingår i: Journal of personalized medicine. - : MDPI AG. - 2075-4426. ; 11:6
  • Tidskriftsartikel (refereegranskat)abstract
    • There is a clinical need to identify children with poor asthma control as early as possible, to optimize treatment and/or to find therapeutic alternatives. Here, we present the “Systems Pharmacology Approach to Uncontrolled Pediatric Asthma” (SysPharmPediA) study, which aims to establish a pediatric cohort of moderate-to-severe uncontrolled and controlled patients with asthma, to investigate pathophysiological mechanisms underlying uncontrolled moderate-to-severe asthma in children on maintenance treatment, using a multi-omics systems medicine approach. In this multicenter observational case–control study, moderate-to-severe asthmatic children (age; 6–17 years) were included from four European countries (Netherlands, Germany, Spain, and Slovenia). Subjects were classified based on asthma control and number of exacerbations. Demographics, current and past patient/family history, and clinical characteristics were collected. In addition, systems-wide omics layers, including epi(genomics), transcriptomics, microbiome, proteomics, and metabolomics were evaluated from multiple samples. In all, 145 children were included in this cohort, 91 with uncontrolled (median age = 12 years, 43% females) and 54 with controlled asthma (median age = 11.7 years, 37% females). The two groups did not show statistically significant differences in age, sex, and body mass index z-score distribution. Comprehensive information and diverse noninvasive biosampling procedures for various omics analyses will provide the opportunity to delineate underlying pathophysiological mechanisms of moderate-to-severe uncontrolled pediatric asthma. This eventually might reveal novel biomarkers, which could potentially be used for noninvasive personalized diagnostics and/or treatment.
  •  
53.
  •  
54.
  •  
55.
  •  
56.
  •  
57.
  •  
58.
  •  
59.
  •  
60.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-60 av 213
Typ av publikation
tidskriftsartikel (186)
konferensbidrag (18)
forskningsöversikt (7)
rapport (1)
bokkapitel (1)
Typ av innehåll
refereegranskat (190)
övrigt vetenskapligt/konstnärligt (22)
populärvet., debatt m.m. (1)
Författare/redaktör
Fischer, H. (8)
Ohsugi, T. (7)
Winer, B. L. (7)
Longo, F. (7)
Paneque, D. (7)
Torres, D. F. (7)
visa fler...
Bregeon, J. (7)
Lemoine-Goumard, M. (7)
Reimer, A. (7)
Reimer, O. (7)
Tibaldo, L. (7)
de Palma, F. (7)
Kerr, M. (7)
Ajello, M. (7)
Barbiellini, G. (7)
Bellazzini, R. (7)
Bruel, P. (7)
Caliandro, G. A. (7)
Cameron, R. A. (7)
Caraveo, P. A. (7)
Chiang, J. (7)
Ciprini, S. (7)
Cohen-Tanugi, J. (7)
Favuzzi, C. (7)
Fusco, P. (7)
Gargano, F. (7)
Gasparrini, D. (7)
Giglietto, N. (7)
Giordano, F. (7)
Guiriec, S. (7)
Johannesson, G. (7)
Loparco, F. (7)
Lovellette, M. N. (7)
Lubrano, P. (7)
Mazziotta, M. N. (7)
Michelson, P. F. (7)
Mizuno, T. (7)
Monzani, M. E. (7)
Morselli, A. (7)
Nuss, E. (7)
Orlando, E. (7)
Pesce-Rollins, M. (7)
Piron, F. (7)
Porter, T. A. (7)
Raino, S. (7)
Razzano, M. (7)
Siskind, E. J. (7)
Spinelli, P. (7)
Wood, K. S. (7)
Rando, R. (7)
visa färre...
Lärosäte
Karolinska Institutet (106)
Uppsala universitet (28)
Stockholms universitet (25)
Lunds universitet (25)
Göteborgs universitet (18)
Chalmers tekniska högskola (15)
visa fler...
Kungliga Tekniska Högskolan (11)
Linköpings universitet (8)
Malmö universitet (5)
Umeå universitet (4)
Örebro universitet (3)
Högskolan i Halmstad (2)
Linnéuniversitetet (1)
RISE (1)
Karlstads universitet (1)
visa färre...
Språk
Engelska (212)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (62)
Medicin och hälsovetenskap (38)
Teknik (10)
Samhällsvetenskap (8)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy